Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 112.85 INR
Change Today 0.00 / 0.00%
Volume 0.0
KPH On Other Exchanges
Symbol
Exchange
Mumbai
As of 7:40 AM 01/6/15 All times are local (Market data is delayed by at least 15 minutes).

kappac pharma ltd (KPH) Snapshot

Open
--
Previous Close
112.85
Day High
--
Day Low
--
52 Week High
10/14/14 - 425.00
52 Week Low
01/6/15 - 112.85
Market Cap
--
Average Volume 10 Days
0.0
EPS TTM
-0.03
Shares Outstanding
23.8M
EX-Date
11/27/00
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for KAPPAC PHARMA LTD (KPH)

Related News

No related news articles were found.

kappac pharma ltd (KPH) Related Businessweek News

No Related Businessweek News Found

kappac pharma ltd (KPH) Details

Kappac Pharma Limited does not have significant operations. Previously, it was engaged in manufacturing pharmaceutical products. The company was incorporated in 1981 and is based in Mumbai, India.

Founded in 1981

kappac pharma ltd (KPH) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

kappac pharma ltd (KPH) Key Developments

Kappac Pharma Ltd. Announces Unaudited Standalone Earnings Results for the First Quarter Ended June 30, 2015

Kappac Pharma Ltd. announced unaudited standalone earnings results for the first quarter ended June 30, 2015. For the quarter, loss from operations before other income, interest and exceptional items was INR 0.025 million compared to INR 0.152 million for the same period a year ago. Loss from ordinary activates before tax was INR 0.025 million compared to INR 0.152 million for the same period a year ago. Net loss was INR 0.025 million compared to INR 0.152 million for the same period a year ago.

Kappac Pharma Ltd., Board Meeting, Aug 10, 2015

Kappac Pharma Ltd., Board Meeting, Aug 10, 2015. Agenda: To consider unaudited standalone earnings results for the first quarter ended June 30, 2015.

Kappac Pharma Ltd. Announces Audited Standalone Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2015

Kappac Pharma Ltd. announced audited standalone earnings results for the fourth quarter and full year ended March 31, 2015. For the quarter, the company reported loss from operations before other income, interest and exceptional items was INR 0.347 million compared to INR 0.566 million for the same period a year ago. Loss from ordinary activates before tax was INR 0.347 million compared to INR 0.566 million for the same period a year ago. Net loss was INR 0.347 million compared to INR 0.566 million for the same period a year ago. Basic and diluted loss per share before and after extraordinary items was INR 0.01 compared to INR 0.02 for the same period a year ago. For the full year, the company reported loss from operations before other income, interest and exceptional items was INR 0.786 million compared to INR 0.831 million for the same period a year ago. Loss from ordinary activates before tax was INR 0.786 million compared to INR 0.831 million for the same period a year ago. Net loss was INR 0.786 million compared to INR 0.831 million for the same period a year ago. Basic and diluted loss per share before and after extraordinary items was INR 0.03 compared to INR 0.03 for the same period a year ago.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
KPH:IN 112.85 INR 0.00

KPH Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for KPH.
View Industry Companies
 

Industry Analysis

KPH

Industry Average

Valuation KPH Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book 8.6x
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact KAPPAC PHARMA LTD, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.